Channel 1 Educational session
Date
20.11.2020
Time
15:35 - 16:55
Location
Channel 1
Chairs
  • John B. Haanen (Amsterdam, Netherlands)
  • Shigehisa Kitano (Tokyo, NY, Japan)
What are the most exciting new developments in immunotherapy of cancer? (ID 34) Educational session

Neoadjuvant immunotherapy: Why does it work better? (ID 172)

Lecture Time
15:35 - 15:50
Speakers
  • John B. Haanen (Amsterdam, Netherlands)
Location
Channel 1, Virtual Meeting, Virtual Meeting, Singapore
Date
20.11.2020
Time
15:35 - 16:55
What are the most exciting new developments in immunotherapy of cancer? (ID 34) Educational session

CAR-T in solid cancer: What are the hurdles? (ID 173)

Lecture Time
15:50 - 16:05
Speakers
  • Shigehisa Kitano (Tokyo, NY, Japan)
Location
Channel 1, Virtual Meeting, Virtual Meeting, Singapore
Date
20.11.2020
Time
15:35 - 16:55
What are the most exciting new developments in immunotherapy of cancer? (ID 34) Educational session

Combining immunotherapy and angiogenesis inhibition: Is there synergy? (ID 174)

Lecture Time
16:05 - 16:20
Speakers
  • Solange Peters (Lausanne, Switzerland)
Location
Channel 1, Virtual Meeting, Virtual Meeting, Singapore
Date
20.11.2020
Time
15:35 - 16:55
What are the most exciting new developments in immunotherapy of cancer? (ID 34) Educational session

Intratumoral immunotherapy: For whom? (ID 175)

Lecture Time
16:20 - 16:35
Speakers
  • Jonathan Cebon (Heidelberg, Australia)
Location
Channel 1, Virtual Meeting, Virtual Meeting, Singapore
Date
20.11.2020
Time
15:35 - 16:55
What are the most exciting new developments in immunotherapy of cancer? (ID 34) Educational session

LIVE Q&A (ID 176)

Lecture Time
16:35 - 16:50
Speakers
  • John B. Haanen (Amsterdam, Netherlands)
Location
Channel 1, Virtual Meeting, Virtual Meeting, Singapore
Date
20.11.2020
Time
15:35 - 16:55